74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Stevanato Group SpA
Closed
Sector Healthcare
20.7 1.42
Overview
Share price change
24h
Min
20.5
Max
20.97
Income | 75M 96M |
|---|---|
Sales | 18M 278M |
P/E Sector Avg | 45.244 73.394 |
EPS | 0.131 |
Dividend yield | 0.28 |
Profit margin | 34.418 |
Employees | 5,635 |
EBITDA | 52M 103M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +22.82 upside |
Dividend yield Sector Avg | 0.28% 3.09% |
|---|---|
Next Earnings | 6 Mar 2025 |
Market Cap | 5.6B |
|---|---|
Previous open | 19.28 |
Previous close | 20.7 |
News Sentiment
By Acuity
50%
50%
157 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Stevanato Group SpA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Stevanato Group SpA Forecast
Price Target
By TipRanks
22.82% upside
12 Months Forecast
Average 25.67 USD 22.82%
High 28 USD
Low 23 USD
Based on 3 Wall Street analysts offering 12 month price targets forStevanato Group SpA - Dist in the last 3 months.
Sentiment
By Acuity
157 / 393 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
